Phase II: Fisogatinib (BLU-554) 600mg in combination with Sugemalimab (CS1001) 1200mg
📊
Treatment Reviews
See user reviews and ratings for Phase II: Fisogatinib (BLU-554) 600mg in combination with Sugemalimab (CS1001) 1200mg
🔬
Mega-Study
See real-world data analysis for Phase II: Fisogatinib (BLU-554) 600mg in combination with Sugemalimab (CS1001) 1200mg
📚
Meta-Analysis
See a meta-analysis of all available research
🔍
Clinical Trials
See clinical trials related to Phase II: Fisogatinib (BLU-554) 600mg in combination with Sugemalimab (CS1001) 1200mg